Innovations in health care and mortality trends from five cancers in seven European countries between 1970 and 2005

International Journal of Public Health

Volumn 59, Issue 2, 2014, Pages 341-350

  Hoffmann, Rasmus ^a   Plug, Iris ^a   McKee, Martin ^b   Khoshaba, Bernadette ^b   Westerling, Ragnar ^c   Looman, Caspar ^a   Rey, Gregoire ^d   Jougla, Eric ^d   Lang, Katrin ^e   Pärna, Kersti ^e   Mackenbach, Johan P ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^c UPPSALA UNIVERSITY   (Sweden)

^d INSERM   (France)

^e UNIVERSITY OF TARTU   (Estonia)

Author keywords

Amenable mortality; Cancer; Health care innovation; Mortality; Outcome assessment (health care)

Indexed keywords

ADOLESCENT; ADULT; AGED; CHILD; EPIDEMIOLOGY; EUROPE; FEMALE; HEALTH CARE DELIVERY; HUMAN; INFANT; MALE; MASS COMMUNICATION; MIDDLE AGED; MORTALITY; NEOPLASM; OUTCOME ASSESSMENT; PRESCHOOL CHILD; TRENDS; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; CHILD; CHILD, PRESCHOOL; DELIVERY OF HEALTH CARE; DIFFUSION OF INNOVATION; EUROPE; FEMALE; HUMANS; INFANT; MALE; MIDDLE AGED; MORTALITY; NEOPLASMS; OUTCOME ASSESSMENT (HEALTH CARE); YOUNG ADULT;

EID: 84899431464     PISSN: 16618556     EISSN: 1420911X     Source Type: Journal    
DOI: 10.1007/s00038-013-0507-9     Document Type: Article

References (40)

1. Autier P, Boniol M, Gavin A, Vatten LJ (2011) Breast cancer mortality in neighbouring European countries with different levels of screening but similar access to treatment: trend analysis of WHO mortality database. Br Med J 343. doi: 10.1136/bmj.d4411
2. Carr-Hill RA, Hardman GF, Russell IT (1987) Variations in avoidable mortality and variations in health care resources. Lancet 1:789-792
3. Charlton JR, Velez R (1986) Some international comparisons of mortality amenable to medical intervention. Br Med J (Clin Res Ed) 292:295-301 (Pubitemid 16134739)
4. Dama E, Pastore G, Mosso ML, Maule MM, Zuccolo L, Magnani C, Merletti F (2006) Time trends and prognostic factors for survival from childhood cancer: A report from the Childhood Cancer Registry of Piedmont (Italy). Eur J Pediatr 165:240-249. doi: 10.1007/s00431-005-0034-7 (Pubitemid 43289632)
5. de Kok IM, van der Aa MA, van Ballegooijen M, Siesling S, Karim-Kos HE, van Kemenade FJ, Coebergh JW, Netherlands Cancer Registry (2011) Trends in cervical cancer in the Netherlands until 2007: has the bottom been reached? Int J Cancer 128:2174-2181. doi: 10.1002/ijc.25553
6. Department of Health and Social Security (1988) Health services management cervical cancer screening [Health Circular HC(88)1]. Department of Health and Social Security, Heywood
7. Duffy SW, Tabar L, Olsen AH, Vitak B, Allgood PC, Chen THH, Yen AMF, Smith RA (2010) Absolute numbers of lives saved and overdiagnosis in breast cancer screening, from a randomized trial and from the Breast Screening Programme in England. J Med Screen 17:25-30. doi: 10.1258/jms.2009.009094
8. Ferlay J, Shin H, Bray F, Forman D, Mathers C, Parkin D (2010) GLOBOCAN 2008 v2.0, Cancer incidence and mortality worldwide: IARC Cancer Base No. 10. International Agency for Research on Cancer, France
9. Forrest P (1986) Breast Cancer Screening. Report to the Health Ministers of England, Wales, Scotland and Northern Ireland by a working group chaired by Professor Sir Patrick Forrest. London
10. Frei E III, Gehan EA (1971) Definition of cure for Hodgkin's disease. Cancer Res 31:1828-1833
11. Gotzsche PC, Jorgensen KJ, Zahl P-H, Maehlen J (2012) Why mammography screening has not lived up to expectations from the randomised trials. Cancer Causes Control 23:15-21. doi: 10.1007/s10552-011-9867-8
12. Hoffmann R, Plug I, Khoshaba B, McKee M, Mackenbach JP, AMIEHS working group (2012) Amenable mortality revisited: the AMIEHS study. Gac Sanit 27:199-206. doi: 10.1016/j.gaceta.2012.08.004
13. Janssen-Heijnen MLG, Louwman WJ, Van de Poll-Franse LV, Coebergh JWW (2005) Van meten naar weten: 50 jaar kankerregistratie. Compr Cancer Cent South, Eindhoven
14. La Vecchia C, Bosetti C, Lucchini F, Bertuccio P, Negri E, Boyle P, Levi F (2010) Cancer mortality in Europe, 2000-2004, and an overview of trends since 1975. Ann Oncol 21:1323-1360. doi: 10.1093/annonc/mdp530
15. Laara E, Day NE, Hakama M (1987) Trends in mortality from cervical cancer in the nordic countries: Association with organised screening programes. Lancet 1:1247-1249 (Pubitemid 17070815)
16. Leon DA (2011) Trends in European life expectancy: A salutary view. Int J Epidemiol 40:271-277. doi: 10.1093/ije/dyr061
17. Levi F, Lucchini F, Negri E, Boyle P, Vecchia CL (2002) Trends in mortality from Hodgkin's disease in western and eastern Europe. Br J Cancer 87:291-293
18. Mackenbach JP, Looman CW, Kunst AE, Habbema JD, van der Maas PJ (1988) Post-1950 mortality trends and medical care: gains in life expectancy due to declines in mortality from conditions amenable to medical intervention in The Netherlands. Soc Sci Med 27:889-894
19. Mackenbach JP, Bouvier-Colle MH, Jougla E (1990) "Avoidable" mortality and health services: A review of aggregate data studies. J Epidemiol Community Health 44:106-111 (Pubitemid 20190429)
20. Mackenbach JP, Hoffmann R, Khoshaba B, Plug I, Rey G, Westerling R, Pärna K, Jougla E, Alfonso J, Looman CWN, McKee M (2013) Using 'amenable mortality' as indicator of health care effectiveness in international comparisons: results of a validation study. J Epidemiol Community Health 67:139-146
21. Mandelblatt J, Schechter CB, Lawrence W, Yi B, Cullen J (2006) The SPECTRUM population model of the impact of screening and treatment on US breast cancer trends from 1975 to 2000: principles and practice of the model methods. J Natl Cancer Institute 36:47-55
22. Marmot MG, Altman DG, Cameron DA, Dewar JA, Thompson SG, Wilcox M, Independent UKPBCS (2012) The benefits and harms of breast cancer screening: An independent review. Lancet 380:1778-1786. doi: 10.1016/s0140-6736(12)61611-0
23. McGuire WL (1978) Hormone receptors - their role in predicting prognosis and response to endocrine therapy. Semin Oncol 5:428-433 (Pubitemid 9097045)
24. McKee M, Karanikolos M, Belcher P, Stuckler D (2012) Austerity: A failed experiment on the people of Europe. Clin Med 12:346-350
25. Meerding WJ, Polder JJ, de Hollander AEM, Mackenbach JP (2007) Hoe gezond zijn de zorguitgaven?. Rijksinstituut voor Volksgezondheid en Milieu, Bilthoven
26. National Board of Health and Welfare (1986) Screening with Mammography. SOSFS (3)
27. Nur U, Rachet B, Mitry E, Cooper N, Coleman MP (2008) Survival from testicular cancer in England and Wales up to 2001. Br J Cancer 99:S80-S82. doi: 10.1038/sj.bjc.6604597
28. Office of Population Censuses and Surveys (1975/1982) Mortality statistics, Series DH2, vol 1, 9. Office of Population Censuses and Surveys, London, pp 1-14
29. Otto SJ, Fracheboud J, Looman CWN, Broeders MJM, Boer R, Hendriks J, Verbeek ALM, de Koning HJ (2003) Initiation of population-based mammography screening in Dutch municipalities and effect on breast-cancer mortality: A systematic review. Lancet 361:1411-1417. doi: 10.1016/s0140-6736(03)13132-7 (Pubitemid 36515040)
30. Pederson T, Mukherjee S (2011) The Emperor of All Maladies: A biography of cancer. Science 332:423. doi: 10.1126/science.1206460
31. Plug I, Hoffmann R, Mackenbach JP (2011) AMIEHS. Avoidable mortality in the European Union: towards better indicators for the effectiveness of health systems. Final report. Department of Public Health, Erasmus Medical Center Rotterdam. http://amiehs.lshtm.ac.uk
32. Poikolainen K, Eskola J (1986) The effect of health services on mortality: decline in death rates from amenable and non-amenable causes in Finland, 1969-1981. Lancet 1:199-202 (Pubitemid 16135524)
33. Rey G, Aouba A, Pavillon G, Hoffman R, Plug I, Westerling R, Jougla E, Mackenbach J (2011) Cause-specific mortality time series analysis: A general method to detect and correct for abrupt data production changes. Popul Health Metr 9:52
34. Robinson SP, Addada J, Green N, Wong WL, Shaw P, Chakraverty R, Goldstone AH, Macmillan A, Linch DC (2001) Response to short course ESHAP chemotherapy in relapsed and refractory lymphoma. Blood 96:246
35. Rogers EM (2002) Diffusion of preventive innovations. Addict Behav 27:989-993. doi: 10.1016/s0306-4603(02)00300-3 (Pubitemid 36158759)
36. Ryan R, Gross N (1943) The diffusion of hybrid seed corn in two Iowa communities. Rural Sociol 8:15-24
37. Tewari KS, Monk BJ (2009) Recent achievements and future developments in advanced and recurrent cervical cancer: trials of the Gynecologic Oncology Group. Semin Oncol 36:170-180. doi: 10.1053/j.seminoncol.2008.12.008
38. UK Trial of Early Detection of Breast Cancer Group (1988) First results on mortality reduction in the UK Trial of Early detection of breast cancer. Lancet 8608(2):411-416
39. Westerling R (1996) Studies of avoidable factors influencing death: A call for explicit criteria. Q Health Care 5:159-165 (Pubitemid 126509596)
40. Zhang B, Su Z, Qiu P (2009) On jump detection in regression curves using local polynomial Kernel estimation. Pak J Stat 25:505-528